Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

Fred Hutchinson Cancer Center

Tracked across 8 events · 219 articles · First seen May 12, 2026 · Last active Sep 24, 2026

Sentiment
14
Attention
7
Events
8
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Tech
Impact: Co-led the study, expanding its research portfolio beyond cancer into chronic pain genomics.
Jul 27, 2026 · 7 articles
2 5
Tech
A study led by Dr. Dan Theodorescu at the University of Arizona Cancer Center has found that loss of the Y chromosome (LOY) in men's body tissue may serve as one of the earliest indicators…
Impact: Collaborated on the study, supporting the development of new cancer detection methods.
Sep 18, 2026 · 6 articles
7 50
Tech
Impact: The Fred Hutchinson Cancer Center is where Dr. Andrew Coveler is affiliated, who commented on the transformative potential of daraxonrasib.
May 29, 2026 · 74 articles
4 5
Tech
The United States — Food and Drug Administration approved daraxonrasib, a first-of-its-kind daily pill for metastatic pancreatic cancer, sold by Revolution Medicines under the brand name Rasonque. The drug blocks mutated KRAS proteins that drive…
Impact: Its physician called the approval one of the most anticipated, adding clinical endorsement of the drug's significance.
Aug 26, 2026 · 6 articles
4 0
Regulatory
An advisory committee to the United States — Food and Drug Administration voted on Wednesday to recommend approval of Grail Inc.'s Galleri blood test, the first multi-cancer early detection test to reach this stage of…
Impact: Its researcher leads an NCI-funded study on multi-cancer detection feasibility and voiced skepticism about the test.
Sep 23, 2026 · 18 articles
7 40
Regulatory
Impact: The cancer center's expert commented on the approval, reflecting institutional engagement.
Aug 26, 2026 · 92 articles
4 0
Tech
May 13, 2026 · 9 articles
6 0
Tech
May 12, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Fred Hutchinson Cancer Center live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.